Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. Precision System Science Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was 1.64%.
The historical rank and industry rank for Precision System Science Co's ROC (Joel Greenblatt) % or its related term are showing as below:
PCNEF'
s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -85.95 Med: -11.76 Max: 17.48
Current: 4.9
During the past 13 years, Precision System Science Co's highest ROC (Joel Greenblatt) % was 17.48%. The lowest was -85.95%. And the median was -11.76%.
PCNEF's ROC (Joel Greenblatt) % is ranked better than 50.24% of 838
companies
in the Medical Devices & Instruments industry
Industry Median: 4.64
vs PCNEF: 4.90
Precision System Science Co (OTCPK:PCNEF) ROC (Joel Greenblatt) % Explanation
The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Precision System Science Co ROC (Joel Greenblatt) % Chart
PCNEF vs ABT, SYK, MDT: ROC (Joel Greenblatt) % Comparison
For the Medical Devices subindustry, Precision System Science Co's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Precision System Science Co ROC (Joel Greenblatt) % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Precision System Science Co's ROC (Joel Greenblatt) % distribution charts can be found below:
* The bar in red indicates where Precision System Science Co's ROC (Joel Greenblatt) % falls into.
Precision System Science Co ROC (Joel Greenblatt) % Calculation
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:
EBIT stands for Earnings Before Interest and Taxes.
Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.
GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.
Note:
The EBIT data used here is four times the quarterly (Dec. 2025) EBIT data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a ROC (Joel Greenblatt) % of 1.64% mean?
Precision System Science Co (PCNEF) has a ROC (Joel Greenblatt) % of 1.64% as of Dec. 2025. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Precision System Science Co and its competitors. According to the industry distribution chart, Precision System Science Co ranks #417 out of 838 companies in the Medical Devices & Instruments industry, placing it in the top 49.8%.
Is Precision System Science Co's ROC (Joel Greenblatt) % too high?
Precision System Science Co's current ROC (Joel Greenblatt) % is 1.64%. The Medical Devices & Instruments industry median ROC (Joel Greenblatt) % is 4.64. Precision System Science Co's value of 1.64% is 64.7% below this industry median. Based on the distribution chart, Precision System Science Co ranks #417 out of 838 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Precision System Science Co has a GF Score™ of 53/100, reflecting its overall financial health beyond just this single metric.
How does Precision System Science Co's ROC (Joel Greenblatt) % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Precision System Science Co ranks #417 out of 838 companies for ROC (Joel Greenblatt) %. This puts Precision System Science Co in the upper half of its industry. The industry median ROC (Joel Greenblatt) % is 4.64. Precision System Science Co's value of 1.64% is 64.7% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC (Joel Greenblatt) % for a Medical Devices & Instruments company?
The median ROC (Joel Greenblatt) % among Medical Devices & Instruments companies is 4.64, based on 838 companies in the industry. Companies in the top quartile (top 25%) have a ROC (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, ROC (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Precision System Science Co's current ROC (Joel Greenblatt) % of 1.64% is 64.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC (Joel Greenblatt) % mean?
A high ROC (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Precision System Science Co and its competitors. For the Medical Devices & Instruments industry, the median ROC (Joel Greenblatt) % is 4.64 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Precision System Science Co's current ROC (Joel Greenblatt) % is 1.64%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Precision System Science Co stock overvalued right now?
Precision System Science Co (PCNEF) has a current ROC (Joel Greenblatt) % of 1.64%. The stock's GF Value™ is $2.69, compared to a current price of $2.28 — trading 15.2% below its estimated fair value. The current ROC (Joel Greenblatt) % is 1.64% and 64.7% below the Medical Devices & Instruments industry median of 4.64. Precision System Science Co's overall GF Score™ is 53/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC (Joel Greenblatt) % calculated?
ROC (Joel Greenblatt) % is calculated from a company's financial statements. For Precision System Science Co (PCNEF), the current ROC (Joel Greenblatt) % is 1.64% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Precision System Science Co (PCNEF) Overvalued in 2026?
Based on GuruFocus' analysis, Precision System Science Co stock appears to be undervalued.
The current stock price of $2.28 is trading 15.2% below its estimated GF Value™ of $2.69.
Key valuation signals for PCNEF:
ROC (Joel Greenblatt) %: 1.64%
GF Value™: $2.69 vs. price of $2.28 (15.2% below fair value)
Industry Position: 64.7% below the Medical Devices & Instruments median (#417 of 838)
No single metric tells the full story. See the PCNEF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Precision System Science Co Ltd is engaged in the development, manufacture, and sale of vitro diagnosis like genetic testing, protein inspection, automation equipment. The company is also engaged in production and sales of reagents and plastic consumables.
53GF Score
Get the complete analysis for PCNEF
ROC (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PCNEF has been successfully added to your 
